Metastat Inc (MTST) financial statements (2020 and earlier)

Company profile

Business Address 27 DRYDOCK AVE., 2ND FLOOR
BOSTON, MA 02210
State of Incorp. NV
Fiscal Year End February 28
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

2/28/2018
2/28/2017
2/29/2016
2/28/2015
2/28/2014
2/28/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments317783364258483969
Cash and cash equivalents317783364258483969
Receivables  125 20 
Prepaid expense4213339 
Deferred costs11   61 
Prepaid expense and other current assets12 
Total current assets:332804522297576969
Noncurrent Assets
Property, plant and equipment35441549752720453
Other undisclosed noncurrent assets44444427910 
Total noncurrent assets:39845854180621553
TOTAL ASSETS:7301,2621,0631,1027911,023
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9567681,009314258168
Accounts payable572572746293258168
Accrued liabilities3431802145  
Interest and dividends payable42164817  
Debt1,0009891,53310028 
Other undisclosed current liabilities124193562  
Total current liabilities:2,0801,9502,598417286168
Noncurrent Liabilities
Long-term debt and lease obligation   170  
Capital lease obligations   170  
Liabilities, other than long-term debt1482,107234   
Derivative instruments and hedges, liabilities1482,107234   
Other undisclosed noncurrent liabilities51  273  
Total noncurrent liabilities:1982,107234443  
Other undisclosed liabilities    2,585719
Total liabilities:2,2794,0572,8328592,871887
Stockholders' equity
Stockholders' equity attributable to parent, including:(1,549)(2,795)(1,770)243(2,081)136
Common stock100322
Additional paid in capital27,95023,52321,60718,9638,6455,496
Accumulated deficit(29,500)(26,319)(23,377)(18,723)(10,728) 
Other undisclosed stockholders' equity attributable to parent0000 (5,362)
Total stockholders' equity:(1,549)(2,795)(1,770)243(2,081)136
TOTAL LIABILITIES AND EQUITY:7301,2621,0631,1027911,023

Income statement (P&L) ($ in thousands)

2/28/2018
2/28/2017
2/29/2016
2/28/2015
2/28/2014
2/28/2013
Revenue, net   75  
Gross profit:23  75 1
Operating expenses(3,574)(3,348)(4,779)(4,791)(4,351)(2,521)
Other operating income (expense), net
(Other Expenses)
369406125(3,204)1,014 
Operating loss:(3,181)(2,942)(4,654)(7,920)(3,337)(2,521)
Nonoperating income   2,483 72
Debt instrument, convertible, beneficial conversion feature   2,325 72
Interest and debt expense(119)(1,376)(317) (104) 
Loss before gain (loss) on sale of properties:(3,300)(4,317)(4,971)(5,437)(3,441)(2,449)
Other undisclosed net income (loss)1191,376317(2,558)(1,924)(72)
Net loss attributable to parent:(3,181)(2,942)(4,654)(7,995)(5,365)(2,521)
Preferred stock dividends and other adjustments 7081,067225  
Other undisclosed net loss available to common stockholders, basic(129)(3,984)(2,402)(467)  
Net loss available to common stockholders, diluted:(3,310)(6,218)(5,989)(8,238)(5,365)(2,521)

Comprehensive Income ($ in thousands)

2/28/2018
2/28/2017
2/29/2016
2/28/2015
2/28/2014
2/28/2013
Net loss:(3,181)(2,942)(4,654)(7,995)(5,365)(2,521)
Comprehensive loss, net of tax, attributable to parent:(3,181)(2,942)(4,654)(7,995)(5,365)(2,521)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: